Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma

Conditions:   nk/T-cell Lymphoma;   Newly Diagnosed;   Advanced Lymphoma Intervention:   Drug: XPO1 inhibitor Sponsor:   Chinese PLA General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials